Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation.

[1]  T. Taki,et al.  The p73 gene is less involved in the development but involved in the progression of neuroblastoma. , 2000, International journal of molecular medicine.

[2]  H. Yokozaki,et al.  Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype , 1999, International journal of cancer.

[3]  J. Herman,et al.  p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. , 1999, Blood.

[4]  Makoto Hijikata,et al.  New p73 variants with altered C-terminal structures have varied transcriptional activities , 1999, Oncogene.

[5]  C. Garbe,et al.  Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines , 1999, International journal of cancer.

[6]  C. Bartram,et al.  Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. , 1999, Blood.

[7]  J. Herman,et al.  Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. , 1999, Cancer research.

[8]  U. Moll,et al.  Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. , 1999, Cancer research.

[9]  B. Clurman,et al.  P73 mutations and expression in adult de novo acute myelogenous leukemia , 1999, Leukemia.

[10]  Yohko Nakamura,et al.  Mutational analysis of the p73 Gene in human breast cancers , 1999, International journal of cancer.

[11]  S. Chi,et al.  Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer. , 1999, Cancer research.

[12]  T. Taki,et al.  Pattern of FHIT gene expression in normal and leukaemic cells , 1999, International journal of cancer.

[13]  C. Harris,et al.  Mutational analysis of p73 and p53 in human cancer cell lines , 1999, Oncogene.

[14]  E. White,et al.  Cancer: DNA damage enables p73 , 1999, Nature.

[15]  Y. Hayashi,et al.  Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children , 1999, British journal of haematology.

[16]  D. Tindall,et al.  Overexpression of the wild type p73 gene in human bladder cancer , 1999, Oncogene.

[17]  Y. Hayashi,et al.  Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. , 1999, Leukemia research.

[18]  F. McKeon,et al.  p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent , 1999, Oncogene.

[19]  G. Melino,et al.  Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity , 1998, Journal of Experimental Medicine.

[20]  S. Swendeman,et al.  Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  D. Tindall,et al.  Activation of p73 silent allele in lung cancer. , 1998, Cancer research.

[22]  A. Nakagawara,et al.  Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. , 1998, Cancer Research.

[23]  S. Nomoto,et al.  Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. , 1998, Cancer research.

[24]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[25]  Y. Hayashi,et al.  The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. , 1997, Blood.

[26]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Azim Surani,et al.  Parental-origin-specific epigenetic modification of the mouse H19 gene , 1993, Nature.

[29]  T. Dryja,et al.  Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. , 1991, American journal of human genetics.

[30]  B. Migeon.  Insights into X chromosome inactivation from studies of species variation, DNA methylation and replication, and vice versa. , 1990, Genetical research.

[31]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[32]  T. Taki,et al.  Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. , 2000, Leukemia research.

[33]  F. Haluska,et al.  Mutational and expression analysis of the p73 gene in melanoma cell lines. , 1999, Cancer research.